LYRA – lyra therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Lyra Therapeutics, Inc. (NASDAQ: LYRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form 10-Q Lyra Therapeutics, Inc. For: Mar 31
Form 8-K Lyra Therapeutics, Inc. For: Apr 30
Form DEFA14A Lyra Therapeutics, Inc.
Form DEF 14A Lyra Therapeutics, Inc. For: Jun 13
Form PRE 14A Lyra Therapeutics, Inc. For: Jun 13
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.